EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Enhancing HER2 testing in breast cancer: predicting fluorescence in situ hybridization ( FISH ) scores from immunohistochemistry images via deep learning

Daniel O Macaulay iD, Wenchao Han, Mark D Zarella, Chris A Garcia, Thomas E Tavolara

The Journal of Pathology: Clinical Research · 2025-03 · 11 (2)

DOI: 10.1002/2056-4538.70024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, online erschienen am 06.03.2025. Verfasst von Daniel O Macaulay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Computational Pathology and AI, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, In Situ Hybridization, Fluorescence, Deep Learning. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer affects millions globally, necessitating precise biomarker testing for effective treatment. HER2 testing is crucial for guiding therapy, particularly with novel antibody‐drug conjugates (ADCs) like trastuzumab deruxtecan, which shows promise for breast cancers with low HER2 expression. Current HER2 testing methods, including immunohistochemistry (IHC) and in situ hybridization (ISH), have limitations. IHC, a semi‐quantitative assay, is prone to interobserver variability. While ISH provides higher precision than IHC, it remains more resource‐intensive in terms of cost and workflow. However, turnaround time is typically faster than that of other advanced molecular methods such as next‐generation sequencing. We adapted the clustering‐constrained‐attention multiple‐instance deep learning model to improve IHC testing and reduce dependence on reflex fluorescence ISH (FISH) tests. Using 5,731 HER2 IHC images, including 592 cases with FISH testing, we trained two models: one for predicting HER2 scores from IHC images and another for predicting FISH scores from equivocal cases. The HER2 IHC score prediction model achieved 91% ± 0.01 overall accuracy and a receiver operating characteristic (ROC) area under the curve (AUC) of 0.98 ± 0.01. The FISH score prediction model had an ROC AUC of 0.84 ± 0.07, with sensitivity at 0.37 ± 0.13 and specificity at 0.96 ± 0.03. External validation on cases from 203 institutions showed similar performance. The HER2 IHC model maintained a 91% ± 0.01 accuracy and an ROC AUC of 0.98 ± 0.01, while the FISH model had an ROC AUC of 0.75 ± 0.03, with sensitivity at 0.28 ± 0.04 and specificity at 0.93 ± 0.01. Our model advances HER2 scoring by reducing subjectivity and variability in current scoring methods. Despite lower accuracy and sensitivity in the FISH prediction model, it may be a beneficial option for settings where reflex FISH testing is unavailable or prohibitive. With high specificity, our model can serve as an effective screening tool, enhancing breast cancer diagnosis and treatment selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesIn Situ Hybridization, FluorescenceDeep LearningImmunohistochemistryBiomarkers, TumorHumansFemalePredictive Value of Tests

Stichwörter der Autor:innen

HER2biomarkersbreast cancerdeep learningfluorescenceimmunohistochemistryin situ hybridization

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, TumorERBB2 protein, human

Autor:innen und Institutionen

  • Division of Computational Pathology and AI, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: Daniel O Macaulay

Zitieren

APA

Macaulay, D. O., Han, W., Zarella, M. D., Garcia, C. A., & Tavolara, T. E. (2025). Enhancing HER2 testing in breast cancer: predicting fluorescence in situ hybridization ( FISH ) scores from immunohistochemistry images via deep learning. The Journal of Pathology: Clinical Research, 11(2). https://doi.org/10.1002/2056-4538.70024

Vancouver

Macaulay DO, Han W, Zarella MD, Garcia CA, Tavolara TE. Enhancing HER2 testing in breast cancer: predicting fluorescence in situ hybridization ( FISH ) scores from immunohistochemistry images via deep learning. The Journal of Pathology: Clinical Research. 2025;11(2). doi:10.1002/2056-4538.70024

BibTeX
@article{Macaulay2025,
  author = {Macaulay, Daniel O and Han, Wenchao and Zarella, Mark D and Garcia, Chris A and Tavolara, Thomas E},
  title = {Enhancing HER2 testing in breast cancer: predicting fluorescence in situ hybridization ( FISH ) scores from immunohistochemistry images via deep learning},
  journal = {The Journal of Pathology: Clinical Research},
  year = {2025},
  volume = {11},
  number = {2},
  doi = {10.1002/2056-4538.70024}
}
Kostenlos starten →